Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

被引:292
作者
Wilde, Arthur A. M. [1 ]
Bhuiyan, Zahurul A. [1 ]
Crotti, Lia [2 ,3 ]
Facchini, Mario [4 ]
De Ferrari, Gaetano M. [3 ]
Paul, Thomas [5 ]
Ferrandi, Chiara [3 ]
Koolbergen, Dave R. [1 ]
Odero, Attilio [2 ,3 ]
Schwartz, Peter J. [2 ,3 ,4 ,6 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Pavia, I-27100 Pavia, Italy
[3] IRCCS, Fdn Policlin S Matteo, Pavia, Italy
[4] IRCCS, Ist Auxol, Milan, Italy
[5] Univ Gottingen, Univ Childrens Hosp, Gottingen, Germany
[6] Univ Cape Town, ZA-7925 Cape Town, South Africa
关键词
D O I
10.1056/NEJMoa0708006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Catecholaminergic polymorphic ventricular tachycardia is a potentially lethal disease characterized by adrenergically mediated ventricular arrhythmias manifested especially in children and teenagers. Beta-blockers are the cornerstone of therapy, but some patients do not have a complete response to this therapy and receive an implantable cardioverter-defibrillator (ICD). Given the nature of catecholaminergic polymorphic ventricular tachycardia, ICD shocks may trigger new arrhythmias, leading to the administration of multiple shocks. We describe the long-term efficacy of surgical left cardiac sympathetic denervation in three young adults with catecholaminergic polymorphic ventricular tachycardia, all of whom had symptoms before the procedure and were symptom-free afterward.
引用
收藏
页码:2024 / 2029
页数:6
相关论文
共 25 条
[21]   Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death [J].
Sumitomo, N ;
Harada, K ;
Nagashima, M ;
Yasuda, T ;
Nakamura, Y ;
Aragaki, Y ;
Saito, A ;
Kurosaki, K ;
Jouo, K ;
Koujiro, M ;
Konishi, S ;
Matsuoka, S ;
Oono, T ;
Hayakawa, S ;
Miura, M ;
Ushinohama, H ;
Shibata, T ;
Niimura, I .
HEART, 2003, 89 (01) :66-70
[22]   Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts [J].
Swan, H ;
Piippo, K ;
Viitasalo, M ;
Heikkilä, P ;
Paavonen, T ;
Kainulainen, K ;
Kere, J ;
Keto, P ;
Kontula, K ;
Toivonen, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (07) :2035-2042
[23]   Ryanodine receptor/calcium release channel PKA phosphorylation: A critical mediator of heart failure progression [J].
Wehrens, XHT ;
Lehnart, SE ;
Reiken, S ;
Vest, JA ;
Wronska, A ;
Marks, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (03) :511-518
[24]  
WOLF MJ, 2007, HEART RHYTHM, V4
[25]  
Zipes D.P., 2006, J Am Coll Cardiol, V48, pe247, DOI [10.1016/j.jacc.2006.07.010, DOI 10.1016/J.JACC.2006.07.010]